HCN/hyperpolarization-activated cyclic nucleotide-gated channel

ZD7288 functions as an activating ring-labeled gated (HCN) channel blocker, both transient and ultra-transient. Glutathione release is inhibited by ZD7288 in a concentration-inhibitory way. Following a 24-hour buffering period with 1, 5, and 50 μM ZD7288, the extracellular fluid's glutamate level dropped to 69.0±2.8%, 31.4±2.0%, and 4.4±0.3%, respectively (P<0.01, when compared to the DMEM/F12 group Ratio [100.2±4.2%]). Once ZD7288 (25) amino acids were added for 20 minutes, the [Ca2+]i generated by 50 μM glutamate increased to 59.2±2.7%, 41.4±2.3%, and 21.0±1.4% for glutamate, respectively (P <0.01, in comparison to the 50 μM glutamate group)[1].

---

Next, we examined the effect of ZD7288on glutamate release in cultured hippocampal neurons. ZD7288 inhibited glutamate release in a concentration-dependent manner (Figure 3B). After incubation with 1, 5 and 50 µM ZD7288 for 24 hours, glutamate content in extracellular fluid was decreased to 69.0 ± 2.8%, 31.4 ± 2.0% and 4.4 ± 0.3%, respectively (P < 0.01, vs. DMEM/F12 group [100.2 ± 4.2%].
It has been reported that the activity of Ih channels can be enhanced by elevating cAMP levels. To confirm that the inhibitory effect of ZD7288on glutamate release is Ih channel-dependent, we explored the effects of pharmacological elevation of cAMP levels on glutamate release, using forskolin and 8-Br-cAMP. After incubation with 5 and 50 µM 8-Br-cAMP, glutamate content in extracellular fluid increased to 136.1 ± 7.4% and 188.1 ± 13.8% respectively (P < 0.01, vs. DMEM/F12 group). Moreover, after incubation with forskolin (1 and 5 µM), extracellular glutamate content was increased to 177.6 ± 6.8% and 308.7 ± 6.9%, respectively (P < 0.01, vs. DMEM/F12 group).

---

Effect of ZD7288 on glutamate-induced [Ca2+]i rise in rat hippocampal neurons [1]
Intracellular calcium plays an important role in transmitter release. We therefore also measured the effect of ZD7288 on intracellular calcium levels. In cultured hippocampal neurons, glutamate (50 µM) evoked a significant increase of [Ca2+]i 78.0 ± 3.3% increase above baseline. After incubation with ZD7288 (25, 50, or 100µM) for 20 minutes, 50 µM glutamate-induced [Ca2+]i rises were attenuated to 59.2 ± 2.7%, 41.4 ± 2.3% and 21.0 ± 1.4%, respectively glutamate (P < 0.01, vs. 50 µM glutamate group; Figure 4). ZD7288 attenuated the glutamate-induced [Ca2+]i rise in a concentration-dependent manner. We also explored the effect of 8-Br-cAMP on glutamate-induced [Ca2+]i rise. 8-Br-cAMP facilitated the glutamate-induced rise in [Ca2+]i (Figure 4). After incubation with 5 and 50 µM 8-Br-cAMP for 5 minutes, glutamate-induced [Ca2+]i increased by 101.3 ± 3.1% and 125.4 ± 3.4%, respectively (P < 0.01, vs. 50 µM glutamate group). After incubation with ZD7288 for 20 minutes, 50 µM 8-Br-cAMP increased the glutamate-induced rise in [Ca2+]i by 86.2 ± 3.3% (P < 0.01, vs. 50 µM 8-Br-cAMP group). Treatment with 50 µM ZD7288 almost completely reversed the facilitation of 8-Br-cAMP in [Ca2+]i.

The amplitude of field excitatory postsynaptic potentials (fEPSP) was dramatically reduced when ZD7288 0.1 μM was applied five minutes before to high-frequency stimulation. This inhibitory effect persisted for the duration of the recording. Thirty minutes after high-frequency stimulation, application of 0.1 μM ZD7288 nearly reversed established long-term potentiation (LTP). Five minutes prior to high-frequency stimulation, ZD7288 (0.1 μM) application resulted in a 74.9±8.0% (P<0.05) reduction in glutamate content when compared to the normal saline group. Furthermore, 30 minutes following high-frequency stimulation, applying 0.1 μM ZD7288 could dramatically lower glutamic acid concentration, which reached 77.0%±9.4% (P<0.05) when compared to the normal saline group [1].\n

---

\n\nEffects of ZD7288 on the induction of LTP at the perforant path–CA3 synapse in rats [1]
\nOur previous study in vivo showed that ZD7288 depressed basal synaptic transmission at the perforant path–CA3 synapse in a concentration-dependent manner (Zheng et al., 2006). Here, we have shown that ZD7288 and CsCl blocked the induction of LTP at the perforant path–CA3 synapse. High-frequency stimulation caused a marked increase in amplitude of the fEPSP in rats that received normal saline over the 90-minute recording period, and the mean magnitude of fEPSP was 281.8 ± 6.6% of the baseline value (P < 0.05; Figure 1). LTP was induced in the perforant path–CA3 synapse by high-frequency stimulation of perforant path fibers. However, application of ZD7288 0.1 µM at 5 minutes before high-frequency stimulation significantly decreased the amplitude of fEPSP, and this inhibitory effect was maintained throughout the recording period. At 30, 60 and 90 minutes after high-frequency stimulation, fEPSP amplitudes were 92.4 ± 10.1%, 85.6 ± 12.0% and 85.2 ± 11.8% of baseline respectively (P < 0.01, vs. normal saline group). The induction of LTP was markedly suppressed by ZD7288.\n

---

\n\nTo confirm that the ZD7288-induced reduction of LTP was due to its role of blocking Ih channels, we used another known Ih blocker, Cs+, commonly used as a diagnostic tool for Ih (Wickenden et al., 2009), to test its effect on LTP induction. Cs+ (1 mM) significantly inhibited the induction of LTP at the perforant path–CA3 synpase. fEPSP amplitudes were significantly lower at each time point after application of CsCl (1 mM) 5 minutes before high-frequency stimulation. At 30, 60 and 90 minutes after high-frequency stimulation, fEPSP amplitudes were 41.6 ± 12.8%, 75.6 ± 11.6% and 78.1 ± 5.5% of baseline, respectively (P < 0.01, vs. normal saline group). The inhibitory effect of Cs+ on LTP was attenuated over time. Our results indicate that Ih channels are involved in the induction of LTP at perforant path–CA3 synapses.\n

---

\n\nEffect of ZD7288 on LTP maintenance at perforant path–CA3 synapses in rats [1]
\nTo further study the role of Ih channels in the maintenance of LTP, the effect of ZD7288 on previously-established LTP was examined. Application of 0.1 µM ZD7288 30 minutes after high-frequency stimulation almost completely reversed the established LTP (Figure 2). Amplitudes were 92.6 ± 6.4% and 88.9 ± 7.6% of baseline at 60 and 90 minutes after high-frequency stimulation, respectively (P < 0.01, vs. normal saline group). Application of 1 mM CsCl 30 minutes after high-frequency stimulation produced similar inhibitory effects. fEPSP amplitudes were 62.6 ± 7.6% and 84.8 ± 18.8% of baseline at 60 and 90 minutes after high-frequency stimulation, respectively (P < 0.01, vs. normal saline group). Moreover, the inhibitory effect of CsCl decreased with time. These results demonstrate that ZD7288 and Cs+ block LTP maintenance at perforant path–CA3 synapses in rats.\n

---

\n\nEffect of ZD7288 on glutamate release in the hippocampus [1]
\nIn some neurons, presynaptic Ih channels regulate synaptic transmission by controlling transmitter release. Glutamate plays an important role in LTP formation at the perforant path–CA3 synapse, of which the LTP induction is N-methyl-D-aspartate receptor-dependent (McMahon and Barrionuevo, 2002). We examined the effect of ZD7288 on glutamate release in hippocampal tissues. Application of high-frequency stimuli resulted in a slight increase of glutamate levels in rats that received normal saline (Figure 3A). Glutamate levels were increased to 111.1 ± 9.6% (P > 0.05, vs. control rats receiving normal saline and no high-frequency stimulation [138.4 ± 34.3 µmol/g protein, normalized as 100 ± 8.8%]). Following application of ZD7288 (0.1 µM) 5 minutes before high-frequency stimulation, glutamate content was reduced to 74.9 ± 8.0% (P < 0.05, vs. normal saline group). CsCl (1 mM) application before high-frequency stimulation produced the same effect as ZD7288; glutamate content was decreased to 71.9 ± 10.0% (P < 0.05, vs. normal saline group). Furthermore, application of 0.1 µM ZD7288 30 minutes after high-frequency stimulation markedly decreased the glutamate content to 77.0% ± 9.4% (P < 0.05, vs. normal saline group). The glutamate content was reduced to 82.5% ± 9.1% when application with 1 mM CsCl after high-frequency stimulation. However, there was no significant difference compared with normal saline group (P > 0.05, vs. normal saline group).\n\n

Neuronal culture [1]
Primary hippocampal neurons were obtained from neonatal (1–2 day-old) Sprague-Dawley rats. Rats were decapitated and brains were rapidly removed and placed in ice-cold phosphate buffered saline. The hippocampus was dissected out and digested with 0.125% trypsin for 20 minutes at 37°C, followed by mechanical dissociation and centrifugation at 1,000 × g for 8 minutes. Cells were resuspended and plated on 96-well plates (for amino acid analysis) or poly-D-lysine-coated coverslips (for measurement of internal calcium concentration, [Ca2+]i). Neurons were cultured in Dulbecco's modified Eagle's medium/Ham's Nutrient Mixture F12 with 10% fetal bovine serum, 100 U/L penicillin, 100 mg/L streptomycin and 0.5 mM glutamine, and kept at 37°C in a 5% CO2 incubator. 10 mg/L arabinosylcytosine was added to the medium at 72 hours to reduce the number of non-neuronal cells. Half of the medium was changed every 2 days. Experiments were performed on days 8–11. The cells were incubated for 24 hours with ZD7288 (1, 5, or 50 µM), 8-bromoadenosine cyclic adenosine monophosphate (8-Br-cAMP, 5 or 50 µM), or forskolin (1 or 5 µM), and the culture medium was collected for glutamate measurement.

---

Glutamate measurement [1]
After LTP recording, the ipsilateral hippocampus was carefully dissociated from the brain, washed with ice-cold normal saline, and frozen at −80°C until processing. The thawed tissue was homogenized in 0.4 M perchloric acid. After aliquots were taken for protein determination, the homogenate was centrifuged at 10,000 × g for 15 minutes at 4°C. The homogenate was then neutralized with 2 M KHCO3 and centrifuged at 3,000 × g for 5 minutes. The supernatant was frozen at −80°C for analysis. Protein levels were measured using Coomassie Brilliant Blue. The neuronal culture medium was collected after 24 hours of drug incubation and centrifuged at 3,000 × g for 5 minutes. The supernatant was stored at −80°C for analysis. Following automatic precolumn derivatization with O-phthaldialdehyde as previously described (McMahon and Barrionuevo, 2002), glutamate analysis was performed using high performance liquid chromatography (Kromasil ODS2 C18 column) with fluorescence detection using a spectrophotometer (excitation wavelength 330 nm, emission wavelength 420 nm). The external standard method was used to quantify the concentration of glutamate according to each peak area. Data were normalized against baseline glutamate values obtained from hippocampal tissue infused with saline and neurons treated with DMEM/F12. Glutamate level in each sample was expressed as the ratio of glutamate in the sample to the baseline value.

---

Measurement of [Ca2+]i [1]
[Ca2+]i measurements were performed according to our previous study in neurons (Huang et al., 2009). Cultured hippocampal neurons were incubated with 1 µM Fura-2 acetoxy-methylol ester for 30 minutes at 37°C, washed three times with artificial cerebrospinal fluid (containing 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose and 10 mM hydroxyethyl piperazine ethanesulfonic acid, pH 7.3), and then incubated at room temperature in the dark for 30 minutes. Fura-2 fluorescence was observed by a Ratio Vision digital fluorescence microscopy system. Fluorescence signals were evoked by 340 and 380 nm excitation wavelengths and collected at 510 nm by TILLvisION 4.0 software. The 340:380 nm fluorescence ratio was used to represent [Ca2+]i. Peak calcium change was represented as the percentage increase from baseline. Neurons were incubated in ZD7288 (25, 50 or 100 µM) or 8-Br-cAMP (5 or 50 µM) for 15 minutes prior to stimulation with 50 µM glutamate. All experiments were repeated in triplicate, using different batches of cells across 4–5 dishes.

Electrophysiological recordings in vivo [1]
Animals were anesthetized intraperitoneally with urethane 1.2 g/kg and fixed in a stereotaxic frame. Body temperature was kept at 37 ± 0.5°C during the experiment, using a constant temperature water cycling system. The skull landmark bregma was chosen as the stereotaxic reference point. Small holes were made in the skull and a stimulating electrode (bipolar stainless steel, 140 µm diameter) was placed at the perforant path (6.8–7.0 mm anteroposterior, 4.3–4.5 mm rostrolateral, depth 3.0–4.0 mm) and a recording electrode (monopolar stainless steel, 140 µm diameter) was positioned in ipsilateral hippocampal CA3 (3.3–3.5 mm anteroposterior, 3.3–3.5 mm rostrolateral). The depth of the recording electrode was determined by the maximal response. Test stimuli were given every 2 seconds (0.5 Hz, 0.15 ms duration) with a programmable electric stimulator using an isolation unit. Field excitatory postsynaptic potentials (fEPSPs) were acquired, amplified, monitored and analyzed with a SMUP-PC biology signal processing system. Baseline fEPSPs were recorded at 50–60% of the maximal response. LTP was then induced by a series of high-frequency stimuli (4 trains of 50 pulses at 100 Hz, 150 µs duration, intertrain interval of 20 seconds). fEPSPs were recorded 90 minutes after high-frequency stimulation. Baseline values were calculated by taking the mean EPSP amplitude at 5 different time points within 30 minutes before high-frequency stimulation. The ratio of absolute fEPSP amplitude to baseline value was used to describe the amplitude level.
For hippocampal administration of saline or drugs, a cannula was carefully inserted into the CA3 area with an introductory tube fixed parallel to the recording electrode, reaching 0.1–0.2 mm higher than the electrode tip.
To test the effects of blockers on the induction of LTP, we applied 0.1 µM ZD7288 or the monovalent cation cesium (Cs+), a known nonspecific Ih antagonist (5 µM CsCl) 5 minutes before high-frequency stimulation. To test the effects of blockers on the maintenance of LTP, ZD7288/Cs+ was slowly administered using an infusion/withdrawal pump 30 minutes after the high-frequency stimulation.

[1]. ZD7288, a selective hyperpolarization-activated cyclic nucleotide-gated channel blocker, inhibits hippocampal synaptic plasticity. Neural Regen Res. 2016 May;11(5):779-86.

4-(N-ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino)pyrimidine chloride is an organic molecular entity. The selective hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blocker 4-(N-ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino)pyrimidine chloride (ZD7288) blocked the induction of long-term potentiation (LTP) in the CA3 region of the hippocampal perforation pathway in rats. To investigate the mechanism of action of ZD7288, we recorded excitatory postsynaptic potentials (EPSPs) at the CA3 synapse in the perforation pathway of male Sprague-Dawley rats. We used high-performance liquid chromatography (HPLC) to determine glutamate levels in the hippocampus and cultured hippocampal neurons, and used Fura-2 to determine intracellular Ca²⁺ concentration [Ca²⁺]i. ZD7288 inhibited the induction and maintenance of long-term potentiation, and the nonspecific HCN channel blocker cesium had a similar effect. ZD7288 also reduced the release of glutamate in hippocampal tissue and cultured hippocampal neurons. In addition, ZD7288 attenuated the glutamate-induced increase in [Ca(2+)]i in a concentration-dependent manner and reversed the promoting effect of 8-Br-cAMP-mediated glutamate-induced increase in [Ca(2+)]i. Our results suggest that ZD7288 inhibits the release of glutamate and the resulting increase in [Ca(2+)]i in rat hippocampal neurons, thereby inhibiting hippocampal synaptic plasticity. [1] Ih channels play an important role in regulating the excitatory and rhythmic activity of neurons. Ih channels are also crucial in synaptic regulation and plasticity. In the well-known hippocampal loop trisynaptic model, ZD7288 inhibits the transmission of the permeabilization pathway-granule cell synapse by inhibiting the postsynaptic glutamate receptor (Chen, 2004). The reduced long-term potentiation (LTP) of moss fibers induced by ZD7288 is due to its inhibition of neurotransmitter release (Mellor et al., 2002). Our previous research has shown that the Ih channel also participates in Schaffer-CA1 pathway LTP by inhibiting N-methyl-D-aspartate receptor function (He et al., 2010). Here, we investigate the role of Ih in synaptic plasticity projecting directly from the cortex to the hippocampus. We focus on the perforation pathway—CA3 synapse, the main pathway projecting from the cortex to the CA3 region of the hippocampus, which mediates memory retrieval. Consistent with previous studies, these findings suggest that perforation pathway input can drive CA3 pyramidal cell firing (Urban et al., 1998; McMahon and Barrionuevo, 2002), and our data indicate that perforation pathway fiber stimulation induces LTP, with the mean fEPSP amplitude remaining at 282% of baseline for more than 1 hour. In addition, ZD7288 treatment inhibited LTP induction and completely reversed established LTP, with the inhibitory effect lasting for at least 1 hour. [1]
In addition to blocking Ih channels (which may lead to nonspecific inhibition of postsynaptic glutamate receptors), ZD7288 also inhibits LTP by inhibiting the perforation pathway-granule cell synapse-mediated response mediated by postsynaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors (Chen, 2004). McMahon and Barrionuevo (2002) showed that perforation pathway-CA3 LTP is NMDA receptor dependent. To investigate whether ZD7288-induced synaptic inhibition is a specific result of Ih channel blockade, we investigated whether its effect was similar to that of another Ih channel blocker, cesium chloride (CsCl). In fact, the LTP inhibition produced by 1 mM CsCl is comparable to that of ZD7288. Application before high-frequency stimulation can block the induction of LTP, while application after high-frequency stimulation can reverse the induction of LTP. These data indicate that when Ih channels are blocked, both the induction and maintenance of LTP are inhibited, suggesting that Ih channels may be directly involved in the induction and maintenance of LTP. However, the inhibitory effect of CsCl gradually weakens over time. Since Cs+ is a non-selective Ih channel blocker, the inhibition of potassium channels may have led to the weakening of this inhibitory effect. [1]
Ih channels are widely distributed in the nervous system and have been identified at the presynaptic terminals in mammals (Southan et al., 2000; Cuttle et al., 2001). These channels are composed of HCN1-HCN4 subunits. HCN1 and HCN2 are located presynaptically in the CA3 pyramidal cell layer (Notomi and Shigemoto, 2004). Numerous previous studies have shown that functional presynaptic Ih channels play a crucial role in synaptic transmission and long-term plasticity by controlling neurotransmitter release (Beaumont and Zucker, 2000; Mellor et al., 2002; Huang and Hsu, 2003). To investigate whether ZD7288 inhibits synaptic plasticity of the perforating CA3 pathway through a presynaptic mechanism, we examined the effect of ZD7288 on glutamate release. We found that before and after high-frequency stimulation, hippocampal glutamate levels in the ZD7288-treated group were lower than those in the saline group, and CsCl (1 mM) also inhibited glutamate release. The increase in glutamate levels after high-frequency stimulation indicates that the stimulation activated glutamatergic neurons. However, the increase in glutamate was not significantly different from that in the control group. This may be because this study used the entire hippocampus to measure glutamate levels. Therefore, we further investigated the effect of ZD7288 on glutamate release using cultured hippocampal neurons. As expected, ZD7288 significantly inhibited glutamate release in cultured cells. Ih channel activation is influenced not only by hyperpolarization but also by intracellular cAMP levels. cAMP enhances Ih channel activity by directly binding to the channel or indirectly activating protein kinase A (Lüthi and McCormick, 1998; Abi-Gerges et al., 2000; Mellor et al., 2002; Genlain et al., 2007). Elevated intracellular cAMP levels and activation of protein kinase A are essential for LTP generation (Pape, 1996; Mellor et al., 2002). ZD7288 inhibits the increase in the frequency of cAMP-triggered micro-excitatory postsynaptic currents by blocking Ih channels (Genlain et al., 2007). In this study, we used the cAMP analog 8-Br-cAMP and the adenylate cyclase activator forskolin to increase cAMP levels. We found that 8-Br-cAMP and forsklin both increased the release of glutamate in cultured hippocampal neurons. These results indicate that the Ih channel is involved in the release of glutamate. ZD7288 inhibits the formation of LTP by inhibiting glutamate release and blocking the Ih channel. [1]
Two mechanisms have been proposed to explain the regulatory role of the Ih channel in glutamate release. One mechanism is related to Ca2+-induced release of Ca2+ from the intracellular calcium pool, suggesting that activation of the Ih channel is accompanied by Ca2+ influx, which triggers the regulatory process (Yu et al., 2004). Another proposed mechanism is that the Ih channel is directly coupled to the release mechanism in a calcium-independent manner (Beaumont and Zucker, 2000). In this study, in order to test whether the inhibition of glutamate release induced by ZD7288 is related to intracellular calcium, we used glutamate as an activator to induce an increase in [Ca2+]i. ZD7288 inhibited glutamate-induced [Ca2+]i elevation in a concentration-dependent manner and reversed 8-Br-cAMP-induced [Ca2+]i elevation. Our data suggest that the inhibitory effect of ZD7288 on glutamate release is due to its attenuation of [Ca2+]i. Activation of Ih channels may enhance Ca2+ influx into the presynaptic terminal through depolarization; the opening of voltage-dependent calcium channels, in turn, leads to a sustained enhancement of glutamate release. Further research is needed to explore the details of this mechanism. [1]
Ih channels are associated with a variety of diseases, including epilepsy, vascular dementia, and peripheral neuropathic pain (Li et al., 2010; Takasu et al., 2010; DiFrancesco et al., 2011). Ischemia is one of the most common damaging factors in the nervous system. Excessive glutamate release and intracellular Ca2+ overload play a key role in ischemic neuronal death (Mori et al., 2004; Zhao et al., 2006). Neuronal overexcitation enhances calcium ion influx, which in turn triggers the release of excitatory neurotransmitters, especially glutamate. Excessive glutamate release during ischemia leads to additional Ca2+ influx. Ih channels are involved in ischemic injury. Our previous studies have shown that HCN1 mRNA and protein expression are reduced in chronic incomplete global cerebral ischemia (Li et al., 2010). We hypothesize that the Ih channel blocker ZD7288 can inhibit glutamate release and glutamate-induced [Ca2+]i elevation, which may help it exert a neuroprotective effect under cerebral ischemia. [1] In summary, the Ih channel blocker ZD7288 can significantly inhibit the long-term potentiation (LTP) of the perforation pathway-CA3 synapse. This inhibition may be due to the reduction of glutamate release and glutamate-induced [Ca2+]i elevation in rat hippocampal neurons.

C15H21CLN4

292.807041883469

292.145

C, 70.28; H, 7.86; N, 21.86

133059-99-1

123983

White to off-white solid powder

359.9ºC at 760 mmHg

171.4ºC

2.31E-05mmHg at 25°C

1

3

3

20

402

0

Cl.N(C1C=CC=CC=1)(CC)C1=C/C(=N\C)/N(C)C(C)=N1

DUWKUHWHTPRMAP-UHFFFAOYSA-N

InChI=1S/C15H20N4.ClH/c1-5-19(13-9-7-6-8-10-13)15-11-14(16-3)18(4)12(2)17-15;/h6-11H,5H2,1-4H3;1H

N-ethyl-1,2-dimethyl-6-methylimino-N-phenylpyrimidin-4-amine;hydrochloride

ZD 7288; ZD-7288; 133059-99-1; 4-Pyrimidinamine, N-ethyl-1,6-dihydro-1,2-dimethyl-6-(methylimino)-N-phenyl-, hydrochloride (1:1); 4-(N-Ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino)pyrimidinium chloride; Zeneca ZD7288; N-ethyl-1,2-dimethyl-6-methylimino-N-phenylpyrimidin-4-amine;hydrochloride; 4-Pyrimidinamine, N-ethyl-1,6-dihydro-1,2-dimethyl-6-(methylimino)-N-phenyl-, monohydrochloride; Ici-D2788; ZD7288

2934.99.9001

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.

Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

DMSO : ~50 mg/mL (~170.76 mM)
H2O : ≥ 50 mg/mL (~170.76 mM)

Solubility in Formulation 1: 100 mg/mL (341.52 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

---

 (Please use freshly prepared in vivo formulations for optimal results.)